InRAD Observational Study

Study acronym: InRAD
StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Site details revised at 2 of 22 sites
  2. Primary endpoint(s) modified
    • Trial sites expanded: 18 → 22 locations
    • Eligibility criteria expanded, about 35 words
  3. Lead sponsor: Stichting International Registry for Alzheimer's Disease and other Dementias Foundation to Stichting International Registry for Alzheimer's Disease and other Dementias Foundation Show 5 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Study sites: 17 to 18
    • Study description expanded, about 13 words
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 4 words
  4. Trial sites expanded: 14 → 17 locationsv12
  5. Study sites: 13 to 14v11
Show 2 earlier versionsHide 2 earlier versions
  1. Study sites: 12 to 13v10
  2. Study sites: 11 to 12v9
  1. Trial sites expanded: 7 → 11 locationsv8
  2. Study sites: 6 to 7v7
  3. Site details revised at 2 of 6 sitesv6
  4. Trial sites expanded: 2 → 6 locations
    • Site contacts updated at 1 of 6 sites
    v5
  5. Study sites: 2 to 6v4
  6. Study sites: 1 to 2
    • Collaborators revised (2)
    v3
  7. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 1, 2026 to Mar 30, 2026
    v2
  8. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this international observational study is to evaluate long-term disease outcomes and treatment safety in people with Alzheimer's disease (PwAD), by collecting real-world data from routine clinical practice across global clinical centers. The InRAD Registry Observational Study has several aims: * To collect medical information for many years from a large group of people with Alzheimer's disease. This will be used for research, which will support improved understanding about the disease. * To enable researchers to look at the effectiveness, usefulness and safety of treatments for Alzheimer's disease. * To enable researchers to answer similar research questions and compare results in many different areas of the world. People with Alzheimer's disease who meet the eligibility criteria and agree to participate in the Study will be asked to visit their doctor (e.g. psychiatrist, geriatrician, or neurologist) at least once a year, or as frequently as is needed for their care. During or after their appointments they may be offered assessments, tests, medications, and treatments as determined by their doctor and their team. This is an observational data collection.
Trial Details
NCT Number NCT07213700
Lead Sponsor Stichting International Registry for Alzheimer's Disease and other Dementias Foundation
Collaborators: InRAD Foundation (Data Processor), Principal Investigator
Conditions
(from sponsor)		 Alzheimer's Disease(AD), Mild Cognitive Impairment (MCI), Subjective Cognitive Decline (SCD), Non-Alzheimer Degenerative Dementia
Related terms Alzheimer Disease, Cognitive Dysfunction, Dementia
Enrollment 50,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov